Flip Therapeutics

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	fliptx.bio
NAICS	541714
Keywords	Immune Medicines And Inflammatory Disease
Founded	2024
Employees	1-10

Key Contact at Flip Therapeutics

Mathias Pawlak

Co-Founder & Member of the Board-elect

Flip Therapeutics Email Formats

Flip Therapeutics uses 1 email format. The most common is {first name} (e.g., john@fliptx.bio), used 100% of the time.

Format	Example	Percentage
{first name}	john@fliptx.bio	100%

About Flip Therapeutics

At Flip, we believe that patients with devastating inflammatory and autoimmune diseases need a new paradigm ... curative therapies. Using in vivo cellular reprogramming, we locally rebalance the immune system to produce durable and potentially curative therapies for T cell driven immune disorders.

Flip Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Flip Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Flip Therapeutics has never raised funding before.

Frequently asked questions

Flip Therapeutics is located in XX.

Flip Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Flip Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Flip Therapeutics

Mathias Pawlak

Co-Founder & Member of the Board-elect

4.8

40,000 users